External Ventricular Drain (EVD) Market – By Product, By Application, By End Use, Global Forecast, 2025 to 2034

External Ventricular Drain Market Size

The global external ventricular drain market was valued at USD 6.3 billion in 2024 and is expected to exhibit growth at a CAGR of 5.6% from 2025 to 2034. High market growth can be attributed to the increasing prevalence of neurological disorders coupled with growing awareness and access to healthcare.
 

Traumatic brain injuries (TBIs) from accidents, falls, and sports injuries are major contributors to increased intracranial pressure (ICP). The CDC reports around 2.8 million TBI-related emergency visits, hospitalizations, and deaths annually in the U.S. As TBI cases rise globally, so does the demand for external ventricular drainage (EVD) systems, crucial for managing ICP and preventing neurological complications.
 

Additionally, governments and health organizations worldwide are investing in improving healthcare infrastructure and accessibility for treating neurological disorders. These initiatives ensure better access to neurosurgical care and essential devices like EVDs, fueling market expansion.
 

An external ventricular drain (EVD) is a temporary medical device used in neurosurgery to relieve elevated intracranial pressure caused by excess cerebrospinal fluid (CSF) accumulation. The device consists of a catheter inserted into the brain's ventricular system, typically through a small hole drilled in the skull, allowing for the drainage of CSF into an external collecting chamber.
 

External Ventricular Drain Market Trends

Technological advancements have significantly driven growth in the external ventricular drain (EVD) market, enhancing the safety, efficacy, and convenience of managing intracranial pressure (ICP) and cerebrospinal fluid (CSF) drainage.
 

• Modern EVD systems now feature integrated sensors and real-time monitoring capabilities, enabling precise measurement of ICP and CSF flow. These technologies improve patient outcomes by allowing clinicians to respond quickly to changes in intracranial dynamics.
   
• Additionally, the development of biocompatible and antimicrobial catheter materials has enhanced the safety of EVD systems. These materials reduce the risk of infections and complications, making EVD procedures more reliable and accessible for a broader range of patients.
   
• Technological innovations have led to the creation of portable and user-friendly EVD systems. These systems are easier to deploy in emergency settings, including trauma centers and intensive care units, making them invaluable for the timely management of neurological conditions.
   

External Ventricular Drain Market Analysis

Based on product, the market is classified into external ventricular drain sets and accessories. The external ventricular drain set segment generated the highest revenue of USD 5.6 billion in 2024.
 

• EVD sets provide a complete solution, ensuring convenience for healthcare providers. Their all-inclusive design reduces the need for sourcing individual components, enhancing procedural efficiency and minimizing the risk of errors during assembly.
   
• The rising prevalence of neurological emergencies such as traumatic brain injuries and strokes has increased the demand for these surgical drainage devices in intensive care units (ICUs) and trauma centers. Their ease of use and availability make them a preferred choice for urgent interventions.
   

Based on application, the external ventricular drain market is classified into traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, and other applications. The traumatic brain injury segment accounted for USD 2.3 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 5.8% between 2025 to 2034 period.
 

• EVD systems are indispensable in treating severe TBI cases, providing a dual function of monitoring ICP and draining excess cerebrospinal fluid (CSF). Their ability to prevent secondary brain damage makes them a critical component of TBI management protocols in neurosurgical and trauma care units.
   
• Additionally, global efforts to enhance the training of medical personnel in handling TBI-related emergencies have contributed to the increased utilization of EVD systems, cementing their role in critical care for brain injuries.

Based on end use, the external ventricular drain market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 6.7 billion by the end of the forecast period.
 

• Hospitals are the first point of care for emergencies such as traumatic brain injuries, strokes, and intracranial hemorrhages, where timely EVD interventions are crucial. The availability of advanced diagnostic and surgical facilities enables hospitals to handle complex neurological cases effectively, driving their reliance on EVD systems.
   
• Modern hospitals are equipped with state-of-the-art operating rooms and intensive care units (ICUs) designed to support EVD procedures. The presence of advanced imaging technologies such as CT and MRI further facilitate precise catheter placement, enhancing the success of EVD interventions.

U.S. external ventricular drain market accounted for USD 2.7 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 5% between the 2025 to 2034.
 

• The U.S. contributes significantly to this dominance due to its large network of trauma centers and specialized neurology hospitals. The high adoption rate of advanced medical devices, supported by favorable reimbursement policies and significant investment in research and development, further strengthens the market in this region.
   
• Additionally, the rising incidence of conditions like hydrocephalus and intracranial hemorrhages contributes to the demand for EVD systems in the U.S.
   

France external ventricular drain market is projected to grow remarkably in the coming years.
 

• The country benefits from a robust network of specialized hospitals and neurology centers that emphasize advanced treatments for brain injuries and neurological disorders.
   
• Public healthcare policies and insurance systems in France ensure that patients have access to critical interventions such as EVD procedures, further driving demand.
   
• Moreover, the increasing awareness about early diagnosis and treatment of intracranial pressure-related conditions bolsters the use of EVD systems in the country.
   

Japan holds a dominant position in the Asia Pacific external ventricular drain market.
 

• The country is known for its early adoption of innovative medical technologies, including advanced EVD systems.
   
• Japan's strong emphasis on research and development in neurosurgical techniques and its highly skilled medical workforce enhance the market growth.
   
• Additionally, the presence of well-equipped hospitals and government initiatives to improve healthcare access further contribute to the demand for EVD systems in Japan.
   

External Ventricular Drain Market Share

The market is competitive, with a mix of large multinationals like B. Braun, Johnson & Johnson, and Medtronic plc leading in innovation and extensive product portfolios. Regional companies and new entrants, particularly from Asia-Pacific (APAC), are also making significant strides. The market is characterized by frequent technological advancements, such as the introduction of smart monitoring systems, improved catheter materials, and integration with imaging technologies, which drive ongoing product development. Strategic partnerships, mergers, and acquisitions are common as companies seek to expand market reach and enhance their technological capabilities.
 

External Ventricular Drain Market Companies

Prominent players operating in the external ventricular drain industry include:

• B. Braun
• Dispomedica
• Fuji Systems
• Integra LifeSciences
• Johnson & Johnson
• Medtronic
• Moller Medical
• Neuromedex
• Sophysa
• Spiegelberg
   

External Ventricular Drain Industry News:

• In July 2023, Integra LifeSciences Holdings Corporation announced positive clinical and economic outcomes for the use of the Codman Bactiseal external ventricular drain (EVD) catheter set in the management of hydrocephalus as a complication of aneurysmal subarachnoid hemorrhage (aSAH) patients. These findings underscore the potential of the Codman Bactiseal EVD catheter set to significantly improve patient outcomes and reduce healthcare costs in this critical area of neurosurgery.
   

The external ventricular drain market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• External ventricular drain sets
• Accessories

Market, By Application

• Traumatic brain injury
• Subarachnoid hemorrhage
• Intracerebral hemorrhage
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE